[1]
Huy, T.L. and Anh, T. Đình . 2022. 22. Treatment result of first-line afatinib for advanced egfr-mutant non-small cell lung cancer in Hanoi Medical University Hospital. Journal of Medical Research. 159, 11 (Nov. 2022), 178-186. DOI:https://doi.org/10.52852/tcncyh.v159i11.1289.